Skip to main content

Opioids

Pax­ton Secures $340 Mil­lion for Texas in Opi­oid Set­tle­ment With Walgreens

Attorney General Paxton announced a $5.7 billion settlement with Walgreens, with over $340 million designated for Texas, for their role in the nationwide opioid epidemic.

May 27, 2023 | Press Release

Pax­ton Secures Over $10 Bil­lion in Opi­oid Funds from CVS and Walgreens

Attorney General Paxton announced that Texas is joining finalized opioid agreements with CVS and Walgreens totaling $10.7 billion nationally, with CVS paying $5 billion and Walgreens paying $5.7 billion.

January 20, 2023 | Press Release

Pax­ton Announces that Texas Has Joined $2.37 Bil­lion Set­tle­ment With Opi­oid Man­u­fac­tur­er Allergan

Attorney General Paxton announced that Texas is joining a $2.37 billion settlement with opioid manufacturer Allergan for its role in the nationwide opioid epidemic.

January 20, 2023 | Press Release

Pax­ton Secures $168M for Texas in Opi­oid Agree­ment with Walmart

Attorney General Paxton announced a planned $3.1 billion settlement with Walmart, with over $168 million designated for Texas, for Walmart’s role in the nationwide opioid epidemic.

December 15, 2022 | Press Release

Pax­ton Urges Fed­er­al Gov­ern­ment to Pro­tect Access to Tele­health Option Enabling Peo­ple to Obtain Treat­ment for Opi­oid Use

Attorney General Paxton has joined a multistate letter urging the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) to permanently extend a Covid-era rule that allows individuals seeking opioid treatment to be prescribed buprenorphine via telemedicine appointments.  

December 09, 2022 | Press Release

Pax­ton Announces Agree­ment in Prin­ci­ple in Opi­oid Set­tle­ment with CVS Phar­ma­cy; Texas to Receive $276 mil­lion Under Pro­posed Deal

Attorney General Paxton announced plans to enter into a $5.034 billion multistate settlement with CVS Pharmacy for its role in the nationwide opioid epidemic, with over $276 million designated for Texas.

November 02, 2022 | Press Release

Pax­ton Launch­es Fri­day Night Lights Against Opi­oids” Coali­tion to Help Fight Opi­oid Epi­dem­ic, Espe­cial­ly Among Young Peo­ple and Stu­dent Athletes

Attorney General Ken Paxton has launched the “Friday Night Lights Against Opioids” coalition and a large-scale pilot program to help stop the opioid epidemic from destroying Texas communities and hurting our young people—especially student athletes.

October 12, 2022 | Press Release

AG Pax­ton Announces $2.37 Bil­lion Agree­ment to Set­tle with For­mer Opi­oid Maker

For the second time this week, Attorney General Paxton and a bipartisan group of attorneys general announced an agreement in principle to address the opioid crisis

July 29, 2022 | Press Release

Opi­oids Mak­er Teva Agrees to $4.25 bil­lion set­tle­ment: Pre­lim­i­nary Agree­ment Will Pro­vide Cash and Nalox­one to Address Opi­oids Crisis

Attorney General Paxton has reached an agreement on key financial terms with opioid maker Teva, which would provide up to $4.25 billion to participating states and local governments.

July 29, 2022 | Press Release

AG Pax­ton Launch­es Inves­ti­ga­tion Into Wal­mart for Poten­tial­ly Deceiv­ing Tex­ans About Opioids

Today Attorney General Ken Paxton issued a Civil Investigative Demand (CID) to Walmart for potential violations of the Texas Deceptive Trade Practices Act (DTPA) relating to the promotion, sale, dispensing, and distribution of prescription opioids.   

June 28, 2022 | Press Release